Fidelity Investments’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220K | Buy |
58,949
+57,587
| +4,228% | +$215K | ﹤0.01% | 3273 |
|
|
2025
Q1 | $3.76K | Sell |
1,362
-112,559
| -99% | -$311K | ﹤0.01% | 4774 |
|
|
2024
Q4 | $631K | Sell |
113,921
-1,058,603
| -90% | -$5.86M | ﹤0.01% | 2832 |
|
|
2024
Q3 | $9.78M | Sell |
1,172,524
-1,594,572
| -58% | -$13.3M | ﹤0.01% | 1929 |
|
|
2024
Q2 | $18.8M | Buy |
2,767,096
+4,970
| +0.2% | +$33.8K | ﹤0.01% | 1675 |
|
|
2024
Q1 | $18.1M | Sell |
2,762,126
-228,276
| -8% | -$1.5M | ﹤0.01% | 1691 |
|
|
2023
Q4 | $19.4M | Sell |
2,990,402
-2,127,648
| -42% | -$13.8M | ﹤0.01% | 1637 |
|
|
2023
Q3 | $25.7M | Sell |
5,118,050
-1,932,296
| -27% | -$9.72M | ﹤0.01% | 1489 |
|
|
2023
Q2 | $61.7M | Sell |
7,050,346
-592,412
| -8% | -$5.18M | 0.01% | 1191 |
|
|
2023
Q1 | $90.5M | Buy |
7,642,758
+264,117
| +4% | +$3.13M | 0.01% | 1021 |
|
|
2022
Q4 | $75.1M | Buy |
7,378,641
+7,277,002
| +7,160% | +$74.1M | 0.01% | 1085 |
|
|
2022
Q3 | $599K | Sell |
101,639
-36
| -0% | -$212 | ﹤0.01% | 2740 |
|
|
2022
Q2 | $252K | Sell |
101,675
-2,219,783
| -96% | -$5.5M | ﹤0.01% | 3069 |
|
|
2022
Q1 | $6.9M | Sell |
2,321,458
-479,527
| -17% | -$1.42M | ﹤0.01% | 2262 |
|
|
2021
Q4 | $19.8M | Sell |
2,800,985
-132,177
| -5% | -$934K | ﹤0.01% | 1830 |
|
|
2021
Q3 | $30.6M | Sell |
2,933,162
-89,395
| -3% | -$932K | ﹤0.01% | 1642 |
|
|
2021
Q2 | $37.1M | Buy |
3,022,557
+134,819
| +5% | +$1.65M | ﹤0.01% | 1570 |
|
|
2021
Q1 | $63.5M | Buy |
+2,887,738
| New | +$63.5M | 0.01% | 1284 |
|